Other Species / Isoforms
  TRAF2 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S5-p
___MAAAsVtPPGsL
0 4
TRAF2 (human) ___MAAAsVtPPGsL S5-p
TRAF2 (mouse) ___MAAAsVTsPGsL S5-p
TRAF2 (rat) ___MAAASVTsPGSL S5
T7-p
_MAAAsVtPPGsLEL
Upstream
0 14
Treatment
  • ischemia
TRAF2 (human) _MAAAsVtPPGsLEL T7-p
TRAF2 (mouse) _MAAAsVTsPGsLEL T7
TRAF2 (rat) _MAAASVTsPGSLEL T7
P8
MAAAsVtPPGsLELL
0 3
TRAF2 (human) MAAAsVtPPGsLELL P8
TRAF2 (mouse) MAAAsVTsPGsLELL S8-p
TRAF2 (rat) MAAASVTsPGSLELL S8-p
S11-p
AsVtPPGsLELLQPG
Upstream
Downstream
5 14
TRAF2 (human)
S11-p
TRAF2 (mouse)
S11-p
Effects on Modified Protein
  • activity, induced
  • molecular association, regulation
  • ubiquitination
Effects on Biological Processes:
  • apoptosis, inhibited
  • carcinogenesis, induced
  • cell growth, induced
  • signaling pathway regulation
Putative in vivo kinases:
  • IKKE (human)
Regulatory protein:
  • PTPRN2 (human)
Treatment
  • camptothecin
  • etoposide
  • H2O2
  • hydroxyurea
  • IGF-1
  • ischemia
  • phorbol_ester
  • TNF
  • tunicamycin
  • UV
TRAF2 (human) AsVtPPGsLELLQPG S11-p
TRAF2 (mouse) AsVTsPGsLELLQPG S11-p
TRAF2 (rat) ASVTsPGSLELLQPG S11
K21
LLQPGFSKtLLGtkL
1 0
TRAF2 (human) LLQPGFSKtLLGtkL K21
TRAF2 (mouse) LLQPGFSkTLLGTRL K21-ub
TRAF2 (rat) LLQPGFSKTLLGTRL K21
T22-p
LQPGFSKtLLGtkLE
0 1
TRAF2 (human) LQPGFSKtLLGtkLE T22-p
TRAF2 (mouse) LQPGFSkTLLGTRLE T22
TRAF2 (rat) LQPGFSKTLLGTRLE T22
T26-p
FSKtLLGtkLEAkYL
0 1
TRAF2 (human) FSKtLLGtkLEAkYL T26-p
TRAF2 (mouse) FSkTLLGTRLEAkYL T26
TRAF2 (rat) FSKTLLGTRLEAKYL T26
K27-ub
SKtLLGtkLEAkYLC
0 11
TRAF2 (human) SKtLLGtkLEAkYLC K27-ub
TRAF2 (mouse) SkTLLGTRLEAkYLC R27
TRAF2 (rat) SKTLLGTRLEAKYLC R27
K31-ub
LGtkLEAkYLCSACR
2 1
TRAF2 (human) LGtkLEAkYLCSACR K31-ub
TRAF2 (mouse) LGTRLEAkYLCSACk K31-ub
TRAF2 (rat) LGTRLEAKYLCSACR K31
R38
kYLCSACRNVLRRPF
1 0
TRAF2 (human) kYLCSACRNVLRRPF R38
TRAF2 (mouse) kYLCSACkNILRRPF K38-ub
TRAF2 (rat) KYLCSACRNILRRPF R38
S55-p
QCGHRYCsFCLASIL
Upstream
Downstream
2 0
Effects on Biological Processes:
  • apoptosis, inhibited
  • transcription, altered
Kinase, in vitro:
  • PKCZ (human)
Putative in vivo kinases:
  • PKCZ (human)
Treatment
  • Aurothiomalate
  • Go_6976
  • Go_6983
  • IGF-1
  • ischemia/reperfusion
  • phorbol_ester
  • phosphatidylcholine
  • TNF
  • UV
TRAF2 (human) QCGHRYCsFCLASIL S55-p
TRAF2 (mouse) QCGHRYCSFCLTSIL S55
TRAF2 (rat) QCGHRYCSFCLTSIL S55
S102-p
AARREVEsLPAVCPS
0 3
TRAF2 (human) AARREVEsLPAVCPS S102-p
TRAF2 (mouse) AARREVESLPAVCPN S102
TRAF2 (rat) AARREVESLPAVCPN S102
T117-p
DGCTWKGtLkEyEsC
Upstream
Downstream
2 0
Effects on Modified Protein
  • activity, induced
Putative upstream phosphatases:
  • PPP2R5C (human)
Treatment
  • TNF
TRAF2 (human) DGCTWKGtLkEyEsC T117-p
TRAF2 (mouse) DGCTWKGtLKEYESC T117-p
TRAF2 (rat) DGCTWKGTLKEYESC T117
K119-ub
CTWKGtLkEyEsCHE
0 2
TRAF2 (human) CTWKGtLkEyEsCHE K119-ub
TRAF2 (mouse) CTWKGtLKEYESCHE K119
TRAF2 (rat) CTWKGTLKEYESCHE K119
Y121-p
WKGtLkEyEsCHEGR
0 1
TRAF2 (human) WKGtLkEyEsCHEGR Y121-p
TRAF2 (mouse) WKGtLKEYESCHEGL Y121
TRAF2 (rat) WKGTLKEYESCHEGL Y121
S123-p
GtLkEyEsCHEGRCP
0 1
TRAF2 (human) GtLkEyEsCHEGRCP S123-p
TRAF2 (mouse) GtLKEYESCHEGLCP S123
TRAF2 (rat) GTLKEYESCHEGLCP S123
K140-ub
LTECPACkGLVRLGE
0 6
TRAF2 (human) LTECPACkGLVRLGE K140-ub
TRAF2 (mouse) LTECPACKGLVRLSE K140
TRAF2 (rat) LTECPACKGLVRLSE K140
S160-p
EHECPERsLSCRHCR
0 1
TRAF2 (human) EHECPERsLSCRHCR S160-p
TRAF2 (mouse) EQECPKRSLSCQHCR S160
TRAF2 (rat) EQECPKRSLSCQHCR S160
K176-ub
PCCGADVkAHHEVCP
0 16
TRAF2 (human) PCCGADVkAHHEVCP K176-ub
TRAF2 (mouse) PCSHVDLEVHYEVCP E176
TRAF2 (rat) PCSHADLELHYEVCP E176
K184-ub
AHHEVCPkFPLTCDG
0 1
TRAF2 (human) AHHEVCPkFPLTCDG K184-ub
TRAF2 (mouse) VHYEVCPKFPLTCDG K184
TRAF2 (rat) LHYEVCPKFPLTCDG K184
K201-ub
KKKIPREkFQDHVkT
0 2
TRAF2 (human) KKKIPREkFQDHVkT K201-ub
TRAF2 (mouse) KKKIPRETFQDHVRA T201
TRAF2 (rat) GKKISQEKLQDHVRT K200
K207-ub
EkFQDHVkTCGKCRV
0 3
TRAF2 (human) EkFQDHVkTCGKCRV K207-ub
TRAF2 (mouse) ETFQDHVRACSKCRV R207
TRAF2 (rat) EKLQDHVRTCSKCRV R206
K231-ub
LETVEGEkQQEHEVQ
0 1
TRAF2 (human) LETVEGEkQQEHEVQ K231-ub
TRAF2 (mouse) SEMVETENLQDHELQ N231
TRAF2 (rat) SELVETEDLQDHELQ D230
K255-ub
LSSVLEAkPLLGDQs
0 50
TRAF2 (human) LSSVLEAkPLLGDQs K255-ub
TRAF2 (mouse) LSSFLEAQASPGTLN Q255
TRAF2 (rat) LSSFLESQASQNQVG Q254
S262-p
kPLLGDQsHAGSELL
0 1
TRAF2 (human) kPLLGDQsHAGSELL S262-p
TRAF2 (mouse) QASPGTLNQVGPELL N262
TRAF2 (rat) LESQASQNQVGPELL N258
S274-p
ELLQRCEsLEkkTAT
0 2
TRAF2 (human) ELLQRCEsLEkkTAT S274-p
TRAF2 (mouse) ELLQRCQILEQKIAT I274
TRAF2 (rat) ELLQRCQILEQKIAT I270
K277-ub
QRCEsLEkkTATFEN
0 1
TRAF2 (human) QRCEsLEkkTATFEN K277-ub
TRAF2 (mouse) QRCQILEQKIATFEN Q277
TRAF2 (rat) QRCQILEQKIATFEN Q273
K278-ub
RCEsLEkkTATFENI
0 1
TRAF2 (human) RCEsLEkkTATFENI K278-ub
TRAF2 (mouse) RCQILEQKIATFENI K278
TRAF2 (rat) RCQILEQKIATFENI K274
K313-ub
QHRLDQDkIEALSSk
0 5
TRAF2 (human) QHRLDQDkIEALSSk K313-ub
TRAF2 (mouse) QHRLDQDKIEALSNK K313
TRAF2 (rat) QHRLDQDKIEALSNK K309
K320-ub
kIEALSSkVQQLERS
0 6
TRAF2 (human) kIEALSSkVQQLERS K320-ub
TRAF2 (mouse) KIEALSNKVQQLERS K320
TRAF2 (rat) KIEALSNKVQQLERS K316
K331-ub
LERSIGLkDLAMADL
0 7
TRAF2 (human) LERSIGLkDLAMADL K331-ub
TRAF2 (mouse) LERSIGLKDLAMADL K331
TRAF2 (rat) LERSIGLKDLAMADL K327
T401-p
IYLNGDGtGRGTHLS
0 2
TRAF2 (human) IYLNGDGtGRGTHLS T401-p
TRAF2 (mouse) VYLNGDGTGRGTHLS T401
TRAF2 (rat) VYLNGDGTGRGTHLS T397
T431-p
WPFNQKVtLMLLDQN
0 1
TRAF2 (human) WPFNQKVtLMLLDQN T431-p
TRAF2 (mouse) WPFNQKVTLMLLDHN T431
TRAF2 (rat) WPFNQKVTLMLLDHN T427
K477-ub
PLFCPVSkMEAkNSY
0 1
TRAF2 (human) PLFCPVSkMEAkNSY K477-ub
TRAF2 (mouse) PLFCPVSKMEAKNSY K477
TRAF2 (rat) PLFCPVSKIEAKNSY K473
K481-ub
PVSkMEAkNSYVRDD
0 17
TRAF2 (human) PVSkMEAkNSYVRDD K481-ub
TRAF2 (mouse) PVSKMEAKNSYVRDD K481
TRAF2 (rat) PVSKIEAKNSYVRDD K477